NCT05165745 (S2P:CWTI) is a NA clinical trial of Individualized Feedback in HIV Prevention, sponsored by Columbia University.

Who is sponsoring NCT05165745?

NCT05165745 is sponsored by Columbia University.

What drugs are being tested in NCT05165745?

Interventions in NCT05165745: Individualized Feedback.

What condition does NCT05165745 study?

NCT05165745 studies HIV Prevention, Pre-exposure Prophylaxis.

Is NCT05165745 still recruiting?

NCT05165745 is currently recruiting now. Last updated 2 September 2025.

Last reviewed 2025-09-02 · How we verify

NCT05165745: S2P:CWTI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stick2PrEP Cisgender Women and Trans Individuals

Recruiting now NA Last updated 2 September 2025

What this trial tests

NA trial testing Individualized Feedback in HIV Prevention in 175 participants. Currently enrolling.

Timeline

25 October 2021

Primary endpoint
25 October 2026

25 October 2026

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	175
Start date	25 October 2021
Primary completion	25 October 2026
Estimated completion	25 October 2026
Sites	1 location across United States

Drugs / interventions tested

Individualized Feedback

Conditions studied

HIV Prevention — all drugs for HIV Prevention →
Pre-exposure Prophylaxis — all drugs for Pre-exposure Prophylaxis →

Sponsor

Columbia University

Who can join

18 and older, any sex, with HIV Prevention or Pre-exposure Prophylaxis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preferences about HIV prevention options, especially as new options become available. This study plans to evaluate preferences over time among cisgender women and trans individuals who are taking medication to prevent HIV, and among cisgender women and trans individuals who are not taking medication but are at risk of HIV. The investigators enroll up to 175 participants who visit the HIV prevention clinic, and the investigators will ask participants to complete questionnaires at regular follow up visits and between visits. This study may help the investigators understand how best to prevent HIV among people at risk.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Individualized Feedback

Trials testing the same drug.

NCT06436690 — Optimizing Antibiotics Prescription · NA · active not recruiting
NCT06768762 — Optimizing a Remote-based Physical Activity Intervention for Adults with Total Knee Replacement · NA · recruiting

Other recruiting trials for HIV Prevention

Currently open trials in the same condition.

NCT07194902 — HIV Self-testing for Partners of HIV-uninfected Postpartum Women · NA · recruiting
NCT07218211 — Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP · Phase 4 · recruiting
NCT07349758 — Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers · Phase 1 · recruiting
NCT07433985 — California MEPS Hub · NA · recruiting
NCT07002866 — Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda · NA · recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05165745 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 2 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05165745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing